Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 07, 2026
Why Is Rivian Automotive (RIVN) Stock Down -10% Today?

Why Is Rivian Automotive (RIVN) Stock Down -10% Today?

Key Takeaways

  • Rivian Automotive RIVN shares fell 10.00% in premarket trading Tuesday, dropping to $16.77 from Monday's close of $18.63.
  • The primary catalyst is Rivian's announcement of an underwritten public offering of 75 million shares of common stock, raising concerns about shareholder dilution.
  • The company also granted underwriters a 30-day option to purchase an additional 11.25 million shares, further amplifying dilution fears.
  • The stock had already dropped roughly 8.5% in after-hours trading Monday following news of the offering, and premarket weakness extended that decline.
  • The dilution concerns come despite recent operational strength, including a raised full-year delivery guidance following a strong second-quarter production and delivery report.
  • Traders are watching the final pricing and size of the share offering, along with how the additional capital will be deployed toward Rivian's R2 production ramp.

Opening Summary

Rivian Automotive, Inc. RIVN is an American electric vehicle manufacturer known for its R1T pickup truck, R1S SUV, and upcoming R2 midsize SUV platform. Shares fell 10.00% in premarket trading Tuesday to $16.77, down from Monday's closing price of $18.63. The sharp decline follows Rivian's announcement of a large stock offering, which triggered an immediate negative market reaction as investors weighed the impact of substantial new share issuance on existing shareholders. The drop marks a reversal from recent strength, as the stock had climbed on positive delivery data just days earlier.

Share Offering Sparks Dilution Concerns

The dominant driver behind Tuesday's selloff is Rivian's disclosure that it has commenced an underwritten public offering of 75 million shares of common stock, with underwriters granted an option to purchase up to 11.25 million additional shares. All shares in the offering are being sold directly by the company, meaning the proceeds will bolster Rivian's cash position but will also meaningfully increase the total share count outstanding. Large share offerings typically pressure stock prices in the near term because existing investors' ownership stakes become diluted, and the market often interprets sizable capital raises as a signal that a company needs additional liquidity to fund ongoing operations or capital-intensive projects like the R2 launch.

Contrast With Recent Operational Strength

The dilution-driven selloff stands in contrast to otherwise positive operational momentum at Rivian. Just days before the offering announcement, the company reported second-quarter 2026 production of 12,613 vehicles and deliveries of 12,194 vehicles, both exceeding its prior guidance range, prompting a 5% stock rally and an upward revision to full-year delivery guidance to between 65,000 and 70,000 vehicles. This divergence highlights how capital markets activity, rather than underlying business fundamentals, is driving Tuesday's price action, with investors weighing near-term dilution against Rivian's improving production trajectory and R2 rollout progress.

Market Context and Trading Activity

Premarket volume in RIVN appears sharply elevated relative to typical premarket activity, consistent with the market digesting a major capital markets announcement rather than routine trading flow. The decline is largely company-specific, tied directly to the share offering news, rather than reflecting broader weakness across the electric vehicle sector or wider market indices. The stock's after-hours slide of roughly 8.5% on Monday, followed by continued premarket weakness Tuesday, suggests the selloff has extended across multiple sessions as investors fully price in the dilution impact.

Trending AI Robots

For traders navigating volatile sessions like this one, Tickeron's Trending AI Robots page offers a curated view of top-performing algorithmic trading bots. Tickeron operates hundreds of AI-driven bots spanning thousands of tickers, but only the strongest performers under current market conditions are highlighted in this trending section. These bots differ by strategy, timeframe, and the specific symbols they track, giving users a snapshot of which automated approaches are currently outperforming amid shifting market conditions. Investors following moves in names like RIVN may find it useful to review how various bot strategies are responding to volatility tied to corporate capital raises.

What Comes Next for RIVN

Rivian's next quarterly earnings report is expected in the coming weeks, and investors will focus closely on how proceeds from the share offering are allocated, particularly toward R2 production ramp-up and manufacturing capacity expansion. Analysts will continue monitoring delivery trends following the raised full-year guidance, as well as updates on tariff mitigation efforts and strategic partnerships, including ties with Amazon and a joint venture with Volkswagen. Key risks include further near-term share-price pressure as the offering is priced and completed, ongoing profitability challenges as the company scales R2 production, and broader sensitivity to shifts in electric vehicle demand and policy support.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: RIVN

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


RIVN in +3.00% Uptrend, advancing for three consecutive days on September 25, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where RIVN advanced for three days, in 221 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

RIVN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RIVN as a result. In 65 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

The Moving Average Convergence Divergence Histogram (MACD) for RIVN turned negative on September 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 39 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 85%.

RIVN moved below its 50-day moving average on August 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for RIVN moved below the 200-day moving average on September 15, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RIVN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

The Aroon Indicator for RIVN entered a downward trend on August 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.386) is normal, around the industry mean (8.777). P/E Ratio (0.000) is within average values for comparable stocks, (494.857). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.479). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (3.253) is also within normal values, averaging (2.589).

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. RIVN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RIVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

Notable companies

The most notable companies in this group are Tesla (NASDAQ:TSLA), General Motors Company (NYSE:GM), Ford Motor Company (NYSE:F), NIO Inc. (NYSE:NIO).

Industry description

Automobiles continue to be arguably the most popular form of passenger travel in the U.S., and major automobile makers have revenues and market capitalizations running into multi-billions. In recent years, the industry has been experiencing some path-breaking innovations like electric vehicles and self-driving technology. While there are long-standing companies like General Motors, Ford, and Toyota Motors operating in this space, there are also emerging/rapidly growing players like Tesla – which has had a major role in the growing popularity of the electric vehicle market. With technological advancements taking steam in the auto space, we’ve also witnessed collaborations (or talks of potential partnerships) of carmakers with tech behemoths like Google’s subsidiary, Waymo.

Market Cap

The average market capitalization across the Motor Vehicles Industry is 72.47B. The market cap for tickers in the group ranges from 669 to 1.47T. TSLA holds the highest valuation in this group at 1.47T. The lowest valued company is PEVM at 669.

High and low price notable news

The average weekly price growth across all stocks in the Motor Vehicles Industry was -6%. For the same Industry, the average monthly price growth was -16%, and the average quarterly price growth was -21%. GGR experienced the highest price growth at 8%, while DCX experienced the biggest fall at -63%.

Volume

The average weekly volume growth across all stocks in the Motor Vehicles Industry was -44%. For the same stocks of the Industry, the average monthly volume growth was 34% and the average quarterly volume growth was -17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 60
Price Growth Rating: 70
SMR Rating: 86
Profit Risk Rating: 91
Seasonality Score: -31 (-100 ... +100)
View a ticker or compare two or three
RIVN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry MotorVehicles

Industry
N/A
Address
14600 Myford Road
Phone
+1 888 748-4261
Employees
15232
Web
https://www.rivian.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Why Is Rivian Automotive (RIVN) Stock Down -10% Today?